| |
| |
|
| Insider
Information: |
Litton Mark James |
| Relationship: |
|
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
246,586 |
|
|
Indirect Shares
|
97,689 |
|
|
| Direct
Value |
$1,929,328 |
|
|
|
Indirect Value
|
$1,472,640 |
|
|
| Total
Shares |
344,275 |
|
|
| Total
Value |
$3,401,968 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alder Biopharmaceuticals Inc |
ALDR |
Chief Business Officer |
2018-06-01 |
102,189 |
2018-06-01 |
78,000 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
|
2024-01-05 |
144,397 |
2024-01-05 |
19,689 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATHA |
Athira Pharma, Inc. |
Chief Operating Officer |
• – – |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
19,689 |
6,563 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2016-10-17 |
4 |
AS |
$27.50 |
$164,998 |
I/I |
(6,000) |
26,000 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2016-06-13 |
4 |
AS |
$28.89 |
$173,664 |
I/I |
(6,000) |
28,000 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Operating OfficerOfficer |
• – – |
2020-09-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,440 |
|
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Operating Officer |
• – – |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
13,126 |
63,566 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Operating Officer |
• – – |
2021-05-18 |
4 |
A |
$14.45 |
$12,528 |
D/D |
867 |
64,433 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2015-07-01 |
4 |
AS |
$51.10 |
$383,219 |
D/D |
(7,500) |
67,655 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2015-10-01 |
4 |
AS |
$32.22 |
$242,002 |
D/D |
(7,500) |
72,919 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2016-01-04 |
4 |
AS |
$31.19 |
$784,951 |
D/D |
(25,000) |
73,718 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2015-04-01 |
4 |
AS |
$27.41 |
$205,553 |
D/D |
(7,500) |
74,359 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2016-05-27 |
4 |
AS |
$30.06 |
$158,693 |
D/D |
(5,280) |
74,567 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2016-05-31 |
4 |
AS |
$30.05 |
$592,566 |
D/D |
(19,720) |
74,567 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2015-06-04 |
4 |
S |
$44.27 |
$1,106,853 |
D/D |
(25,000) |
75,155 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2016-05-27 |
4 |
OE |
$0.39 |
$2,033 |
D/D |
5,280 |
79,847 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2015-09-24 |
4 |
OE |
$1.27 |
$16,146 |
D/D |
12,764 |
80,419 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2015-01-27 |
4 |
AS |
$28.52 |
$65,602 |
D/D |
(2,300) |
81,859 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2015-01-26 |
4 |
AS |
$28.03 |
$145,732 |
D/D |
(5,200) |
84,159 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2014-11-20 |
4 |
S |
$15.63 |
$469,011 |
D/D |
(30,000) |
88,484 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business OfficerOfficer |
• – – |
2014-05-07 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
90,000 |
|
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2016-05-31 |
4 |
OE |
$0.39 |
$7,592 |
D/D |
19,720 |
94,287 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2016-01-04 |
4 |
OE |
$0.39 |
$9,625 |
D/D |
25,000 |
98,718 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2016-07-12 |
4 |
OE |
$0.39 |
$9,625 |
D/D |
25,000 |
99,567 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-01-05 |
4 |
AS |
$23.00 |
$50,972 |
D/D |
(2,216) |
99,932 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-01-06 |
4 |
AS |
$23.02 |
$156,520 |
D/D |
(6,800) |
99,932 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-01-09 |
4 |
AS |
$23.00 |
$11,500 |
D/D |
(500) |
99,932 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
